Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-30

Clinical Trial Update: Gene Transfer Clinical Trial for Krabbe Disease [Phase 1, Phase 2]

View source ↗

Summary

Update on a gene transfer trial for Krabbe disease sponsored by Forge Biologics; the Phase 1/2 study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FB-101 (FB-101)

Snippet

Sponsor: Forge Biologics, Inc | Conditions: Krabbe Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING